OssDsign AB
OSSD
Company Profile
Business description
OssDsign AB is a developer and global provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the US, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the US.
Contact
Rapsgatan 23 A
Uppsala75450
SWESector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
27
Stocks News & Analysis
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
With increased AI spending and hopes of future data center expansion, here’s what we think of Nvidia stock.
stocks
Is this overpriced ASX share too much of a gamble?
We raise our fair value after strong results but shares are pricey.
stocks
ASX players that might thrive under a Trump administration
Recent election results have sent US markets into a record-high rally however implications remain mixed for the Australian share market. See our top ASX picks that could do better under a second Trump administration.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,515.90 | 36.00 | 0.42% |
| CAC 40 | 7,311.80 | 94.97 | 1.32% |
| DAX 40 | 19,263.70 | 260.59 | 1.37% |
| Dow JONES (US) | 43,750.86 | 207.33 | -0.47% |
| FTSE 100 | 8,071.19 | 40.86 | 0.51% |
| HKSE | 19,552.88 | 117.07 | 0.60% |
| NASDAQ | 19,107.65 | 123.07 | -0.64% |
| Nikkei 225 | 38,819.13 | 283.43 | 0.74% |
| NZX 50 Index | 12,719.75 | 26.81 | 0.21% |
| S&P 500 | 5,949.17 | 36.21 | -0.60% |
| S&P/ASX 200 | 8,258.60 | 34.60 | 0.42% |
| SSE Composite Index | 3,387.43 | 7.59 | 0.22% |